TabsDetailsBasic DetailsDate Posted: Tuesday, August 25, 2020Status: CompleteMedical Product: spironolactoneDescription: In this report we examined the number of individuals with reduced ejection fraction heart failure (HFrEF) or preserved ejection fraction heart failure (HFpEF) in the Sentinel Distributed Database (SDD) and described the utilization of spironolactone among these individuals.The study period included data from July 1, 2010 to September 30, 2018. We distributed the request to 16 Data Partners on February 13, 2020. Read More Deliverables (1)Sentinel Modular Program Report: Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF)Additional InformationAdditional DetailsFDA Center: CDERTime Period: July 1, 2010 - September 30, 2018Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Sentinel Distributed Database (SDD)Related Links: ICPE 2020: Utilization of Spironolactone in Patients with Reduced or Preserved Ejection Fraction Heart Failure
